<!DOCTYPE html>
<!-- Generated by Aspose.Words for Java 21.2.0 --><html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>fedlex-data-admin-ch-eli-cc-2021-325-20220701-en-docx</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<!--818.102.2--><p class="srnummer ">818.102.2</p>
<p class=" man-font-style-italic ">English is not an official language of the Swiss Confederation. This translation is provided for information purposes only, has no legal force and may not be relied on in legal proceedings.</p>
<h1 class="erlasstitel botschafttitel ">Ordinance <br>on Certificates to Prove COVID-19 Vaccination, <br>COVID-19 Recovery or a COVID-19 Test Result</h1>
<h2 class="erlasskurztitel ">(COVID-19 Certificates Ordinance)</h2>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">of 4 June 2021 (Status as of 1 July 2022)</p>
</div>
<div id="preamble">
<p>The Swiss Federal Council,</p>
<p>based on Article 6<i>a</i> paragraphs 1, 4 and 5 of the COVID-19 Act of <br>25 September 2020<sup><a href="#fn-d6e32" id="fnbck-d6e32">1</a></sup>,</p>
<p>ordains:</p>
<div class="footnotes"><p id="fn-d6e32"><sup><a href="#fnbck-d6e32">1</a></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2020/711" target="_blank">SR <b>818.102</b></a></p></div>
</div>
<main id="maintext"><section id="sec_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_1">Section 1 Subject Matter </a>
</h1>
<div class="collapseable"> <article id="art_1"><a name="a1"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_1"><b>Art. 1</b> </a>
</h6>
<div class="collapseable">
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">This Ordinance regulates:</p>
<dl>
<dt>a. </dt>
<dd>the form, content, issuance and revocation of the following COVID-19 certificates to prove:<dl>
<dt>1. </dt>
<dd>vaccination against COVID-19 (COVID-19 vaccination certificate),</dd>
<dt>2. </dt>
<dd>recovery from Sars-CoV-2 infection (COVID-19 recovery certificate),</dd>
<dt>3. </dt>
<dd>a negative result following Sars-CoV-2 test analysis (COVID-19 test certificate),</dd>
<dt>4.<sup><a href="#fn-d6e82" id="fnbck-d6e82">2</a></sup> </dt>
<dd>...</dd>
</dl>
</dd>
<dt>b. </dt>
<dd>the specifications for verifying these certificates;</dd>
<dt>c. </dt>
<dd>the recognition of corresponding foreign certificates;</dd>
<dt>d. </dt>
<dd>the information systems operated by the Confederation in connection with these certificates;</dd>
<dt>e. </dt>
<dd>the apps offered by the Confederation for certificate holders and checkers;</dd>
<dt></dt>
<dd></dd>
<dt>f. </dt>
<dd>the tasks of the cantons in connection with issuing and revoking certificates;</dd>
<dt>g.<sup><a href="#fn-d6e130" id="fnbck-d6e130">3</a></sup> </dt>
<dd>the payment of costs by requesting persons.</dd>
</dl>
<div class="footnotes">
<p id="fn-d6e82"><sup><a href="#fnbck-d6e82">2</a></sup> Inserted by No I of the O of 3 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>). Repealed by No I of the O of  16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), with effect from 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e130"><sup><a href="#fnbck-d6e130">3</a></sup> Inserted by No I of the O of 1 Oct. 2021, in force since 11 Oct. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/592" target="_blank">AS <b>2021</b> 592</a>).</p>
</div>
</div></article>
</div></section><section id="sec_2"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_2">Section 2 Issuance, Form and Revocation of COVID-19 Certificates </a>
</h1>
<div class="collapseable"> <article id="art_2"><a name="a2"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_2"><b>Art. 2</b> Request </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Any person wishing to obtain a COVID-19 certificate must submit a request to an issuer specified in Article 6 or 7.</p>
</div></article><article id="art_3"><a name="a3"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_3"><b>Art. 3</b> Information and identification of the requesting person </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The issuer shall inform the requesting person about:</p>
<dl>
<dt>a. </dt>
<dd>the type and extent of the data processing required to create and sign the COVID-19 certificate;</dd>
<dt>b. </dt>
<dd>the conditions under which the issued certificate is revoked.</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The issuer shall verify the identity of the requesting person, with presentation of an identity document for this purpose where necessary.</p>
</div></article><article id="art_4"><a name="a4"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_4"><b>Art. 4</b> Retrieval of the COVID-19 certificate from the system for issuing COVID-19 certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The issuer shall transmit the information to be included in the certificate to the system operated by the Federal Office of Information Technology, Systems and Telecommunication (FOITT) for issuing COVID-19 certificates in accordance with Article 26.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The system generates the certificate. It shall transmit it to the issuer, provided the issuer is responsible for transmitting or delivering the certificate to the requesting person.</p>
</div></article><article id="art_5"><a name="a5"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_5"><b>Art. 5</b> Transmission or delivery of the COVID-19 certificate to the requesting person </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The issuer shall ensure the rapid and secure transmission or delivery of the COVID-19 certificate to the requesting person.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The issuer is responsible for compliance with data protection requirements during transmission and delivery. In particular, it must be ensured that third parties are unable to obtain knowledge of the information contained on the certificate.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> The Confederation may propose to the cantons that it take care of printing the certificates in hard copy and transmitting certificates to requesting persons.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>4</sup> It shall charge the cantons for the costs of printing and transmitting COVID-19 vaccination certificates of people vaccinated from 15 July 2021 onwards.<sup><a href="#fn-d6e224" id="fnbck-d6e224">4</a></sup></p>
<div class="footnotes"><p id="fn-d6e224"><sup><a href="#fnbck-d6e224">4</a></sup> Inserted by No I of the O of 30 June 2021, in force since 3 July 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/410" target="_blank">AS <b>2021</b> 410</a>).</p></div>
</div></article><article id="art_6"><a name="a6"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_6"><b>Art. 6</b>  General provisions concerning the issuers of COVID-19 certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The cantons and the Surgeon General shall designate the respective issuers for the various types of COVID-19 certificates.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> Issuers shall be natural persons who:</p>
<dl>
<dt>a. </dt>
<dd>have the necessary expertise to assess the requirements for issuing certificates;</dd>
<dt>b. </dt>
<dd>use IT systems and products that allow issuers to be uniquely identified and securely authenticated;</dd>
<dt>c. </dt>
<dd>guarantee compliance with the applicable law and in particular with this Ordinance.</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> The cantons and the Surgeon General shall notify the FOITT of the designated issuers. Notification shall include the following information:</p>
<dl>
<dt>a. </dt>
<dd>first name, surname, address, email address and telephone number of the issuer;</dd>
<dt>b. </dt>
<dd>details of the identification provider used and the identifier this provider uses to identify the person concerned;</dd>
<dt>c. </dt>
<dd>details of which certificates the issuer is authorised to issue;</dd>
<dt>d. </dt>
<dd>the date on which designation becomes valid and expires.</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>4</sup> The designated issuers may call on the services of other persons to whom they have the right to give instructions in order to issue certificates. They shall be responsible for the acts and omissions of these persons.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>5</sup> The cantons and the Surgeon General shall supervise the issuance and revocation of certificates by the issuers in accordance with the applicable federal and cantonal regulations.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>6</sup> They shall revoke such designation if there are clear indications that the issuer no longer meets the requirements. They shall notify the FOITT of the revocation of a designation.</p>
</div></article><article id="art_7"><a name="a7"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_7"><b>Art. 7</b> Issuers for the retrospective issuance of COVID-19 vaccination certificates and COVID-19 recovery certificates</a><sup><a href="#fn-d6e308" id="fnbck-d6e308">5</a></sup><a href="#art_7"> </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The cantons and the Surgeon General shall ensure that in the following cases requests for a COVID-19 vaccination certificate or COVID-19 recovery certificate pursuant to Article 16 paragraph 1 letter a are processed, even if an issuer under Article 6 has no access to the relevant medical history or primary documentation for this purpose:<sup><a href="#fn-d6e326" id="fnbck-d6e326">6</a></sup></p>
<dl>
<dt>a. </dt>
<dd>where the person concerned received the vaccination or recovered from an infection confirmed by a molecular-biological analysis in Switzerland;</dd>
<dt>b.<sup><a href="#fn-d6e345" id="fnbck-d6e345">7</a></sup> </dt>
<dd>where a person in the following groups received the vaccination or recovered from an infection confirmed by a molecular-biological analysis abroad:<dl>
<dt>1. </dt>
<dd>Swiss citizens,</dd>
<dt>2. </dt>
<dd>foreign nationals holding a short-stay, residence, settlement or cross-border commuter permit under Articles 32–35 of the Foreign Nationals and Integration Act of 16 December 2005<sup><a href="#fn-d6e369" id="fnbck-d6e369">8</a></sup> (FNIA),</dd>
<dt>3. </dt>
<dd>temporarily admitted persons under Article 83 paragraph 1 FNIA,</dd>
<dt>4. </dt>
<dd>persons in need of protection under Article 66 of the Asylum Act of 26 June 1998<sup><a href="#fn-d6e388" id="fnbck-d6e388">9</a></sup>,</dd>
<dt>5. </dt>
<dd>asylum seekers holding a permit or confirmation under Article 30 of the Asylum Ordinance 1 of 11 August 1999<sup><a href="#fn-d6e402" id="fnbck-d6e402">10</a></sup>,</dd>
<dt>6. </dt>
<dd>persons holding a legitimation card under Article 17 of the Host State Ordinance of 7 December 2007<sup><a href="#fn-d6e416" id="fnbck-d6e416">11</a></sup>,</dd>
<dt>7. </dt>
<dd>persons holding a Ci permit under Article 22 paragraph 3 of the Host State Ordinance.<sup><a href="#fn-d6e430" id="fnbck-d6e430">12</a></sup>
</dd>
</dl>
</dd>
</dl>
<p><sup>1bis</sup> The cantons shall ensure that requests for a COVID-19 recovery certificate pursuant to Article 16 paragraph 1 letters b or c are processed for the following persons even if an issuer under Article 6 has no access to the relevant medical history or primary documentation for this purpose:</p>
<dl>
<dt>a. </dt>
<dd>persons who have received an isolation order;</dd>
<dt>b. </dt>
<dd>persons who have been issued with a COVID-19 recovery certificate pursuant to Article 16 paragraph 1 letter b in its version of 19 January 2022<sup><a href="#fn-d6e455" id="fnbck-d6e455">13</a></sup>.<sup><a href="#fn-d6e465" id="fnbck-d6e465">14</a></sup>
</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> They shall designate at least one issuer for dealing with such requests.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> The request for issuance of a COVID-19 vaccination certificate or COVID-19 recovery certificate under paragraph 1 must be submitted in an official language of the canton, in English or an officially certified translation into one of these languages must be provided together with the documents listed in Articles 13 paragraph 2 letter c and 16.<sup><a href="#fn-d6e489" id="fnbck-d6e489">15</a></sup></p>
<p><sup>4</sup> If there is any doubt as to whether the documents submitted are genuine, the issuer may:</p>
<dl>
<dt>a. </dt>
<dd>demand that the requesting person: <dl>
<dt>1. </dt>
<dd>appear in person,</dd>
<dt>2. </dt>
<dd>submit officially certified documents,</dd>
<dt>3. </dt>
<dd>submit the information or documents required to assess the request;</dd>
</dl>
</dd>
<dt>b. </dt>
<dd>obtain further information from the competent foreign authorities in compliance with Article 62 of the Epidemics Act of 28 September 2012<sup><a href="#fn-d6e530" id="fnbck-d6e530">16</a></sup>.<sup><a href="#fn-d6e539" id="fnbck-d6e539">17</a></sup>
</dd>
</dl>
<p><sup>5</sup> If there is still doubt as to whether the documents submitted are genuine despite taking the foregoing measures, the issuer may decline the request. In such an event, the requesting person is not entitled to a refund of any fee paid.<sup><a href="#fn-d6e553" id="fnbck-d6e553">18</a></sup></p>
<div class="footnotes">
<p id="fn-d6e308"><sup><a href="#fnbck-d6e308">5</a></sup> Amended by Annex No 3 of the O of 17 Dec. 2021, in force since 17 Jan. 2022  (<a href="https://fedlex.data.admin.ch/eli/oc/2021/881" target="_blank">AS <b>2021</b> 881</a>).</p>
<p id="fn-d6e326"><sup><a href="#fnbck-d6e326">6</a></sup> Amended by No I of the O of 27 April 2022 (EU Compatible COVID-19 Recovery Certificates for Rapid Antigen Tests), in force since 2 May 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/258" target="_blank">AS <b>2022</b> 258</a>).</p>
<p id="fn-d6e345"><sup><a href="#fnbck-d6e345">7</a></sup> Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e369"><sup><a href="#fnbck-d6e369">8</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2007/758" target="_blank">SR <b>142.20</b></a></p>
<p id="fn-d6e388"><sup><a href="#fnbck-d6e388">9</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/1999/358" target="_blank">SR <b>142.31</b></a></p>
<p id="fn-d6e402"><sup><a href="#fnbck-d6e402">10</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/1999/359" target="_blank">SR <b>142.311</b></a></p>
<p id="fn-d6e416"><sup><a href="#fnbck-d6e416">11</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2007/861" target="_blank">SR <b>192.121</b></a></p>
<p id="fn-d6e430"><sup><a href="#fnbck-d6e430">12</a></sup> Amended by No I of the O of 2 Feb. 2022, in force since 3 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/60" target="_blank">AS <b>2022</b> 60</a>).</p>
<p id="fn-d6e455"><sup><a href="#fnbck-d6e455">13</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2022/20" target="_blank">AS <b>2022</b> 20</a></p>
<p id="fn-d6e465"><sup><a href="#fnbck-d6e465">14</a></sup> Inserted by No I of the O of 2 Feb. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/60" target="_blank">AS <b>2022</b> 60</a>). Amended by No I of the O of 27 April 2022 (EU Compatible COVID-19 Recovery Certificates for Rapid Antigen Tests), in force since 2 May 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/258" target="_blank">AS <b>2022</b> 258</a>).</p>
<p id="fn-d6e489"><sup><a href="#fnbck-d6e489">15</a></sup> Inserted by No I of the O of 17 Sept. 2021, in force since 20 Sept. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/564" target="_blank">AS <b>2021</b> 564</a>).</p>
<p id="fn-d6e530"><sup><a href="#fnbck-d6e530">16</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2015/297" target="_blank">SR <b>818.101</b></a></p>
<p id="fn-d6e539"><sup><a href="#fnbck-d6e539">17</a></sup> Inserted by No I of the O of 1 Oct. 2021, in force since 11 Oct. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/592" target="_blank">AS <b>2021</b> 592</a>).</p>
<p id="fn-d6e553"><sup><a href="#fnbck-d6e553">18</a></sup> Inserted by No I of the O of 1 Oct. 2021, in force since 11 Oct. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/592" target="_blank">AS <b>2021</b> 592</a>).</p>
</div>
</div></article><article id="art_7_a"><a name="a7a"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_7_a"><b>Art. 7</b><i>a</i></a><sup><a href="#fn-d6e569" id="fnbck-d6e569">19</a></sup><a href="#art_7_a"><i></i> <i></i>Issuers of COVID-19 test certificates for targeted and repetitive tests </a>
</h6>
<div class="collapseable"> <p>The cantons shall ensure that in the following cases requests for a COVID-19 test certificate are processed:</p>
<dl>
<dt>a. </dt>
<dd>in the case of pooled molecular-biological analyses for Sars-CoV-2:<dl>
<dt>1. </dt>
<dd>targeted and repetitive tests in schools, universities and educational institutions for the prevention and early detection of outbreaks,</dd>
<dt>2. </dt>
<dd>targeted and repetitive tests in hospitals, homes for the elderly and care homes, and in other socio-medical institutions that admit persons for treatment or care, for rehabilitation or for socio-professional rehabilitation or employment,</dd>
<dt>3. </dt>
<dd>targeted and repetitive tests in businesses;</dd>
</dl>
</dd>
<dt>b. </dt>
<dd>in the case of individual molecular-biological analyses for Sars-CoV-2 carried out to confirm the positive result of a test conducted in accordance with letter a.</dd>
</dl>
<div class="footnotes"><p id="fn-d6e569"><sup><a href="#fnbck-d6e569">19</a></sup> Inserted by Annex No 3 of the O of 17 Dec. 2021, in force since 17 Jan. 2022  (<a href="https://fedlex.data.admin.ch/eli/oc/2021/881" target="_blank">AS <b>2021</b> 881</a>).</p></div>
</div></article><article id="art_8"><a name="a8"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_8"><b>Art. 8</b> Automated procedure for issuing COVID-19 recovery certificates </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> For the purpose of issuing COVID-19 recovery certificates pursuant to Article 16 paragraph 1, the cantons may use an automated procedure to retrieve information on the requesting person's recovery from the information system in accordance with Article 60 of the Epidemics Act of 28 September 2012<sup><a href="#fn-d6e627" id="fnbck-d6e627">20</a></sup> and compare it with the information in the request.<sup><a href="#fn-d6e636" id="fnbck-d6e636">21</a></sup> </p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> For this purpose, they may provide the requesting person with an electronic request form supplied by the Confederation.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> If the comparison with the data retrieved from the information system shows that the requirements for issuing a certificate are met, the system for issuing COVID-19 certificates (Art. 26) shall generate the certificate.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>4</sup> If the result of the comparison is unclear or negative, the competent cantonal body shall contact the requesting person and manually check whether the requirements for issuing a certificate are met.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>5</sup> The cantons shall ensure that the requesting person may also submit the request in hard copy or in any other suitable form.</p>
<div class="footnotes">
<p id="fn-d6e627"><sup><a href="#fnbck-d6e627">20</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2015/297" target="_blank">SR <b>818.101</b></a></p>
<p id="fn-d6e636"><sup><a href="#fnbck-d6e636">21</a></sup> Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
</div>
</div></article><article id="art_8_a"><a name="a8a"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_8_a"><b>Art. 8</b><i>a</i></a><sup><a href="#fn-d6e669" id="fnbck-d6e669">22</a></sup><a href="#art_8_a"><i></i> <i></i>Automated procedure for converting COVID-19 certificates </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> The Confederation may allow the cantons to issue new certificates using an automated procedure on the basis of existing certificates in order to fulfil their duties pursuant to Article 7 if:</p>
<dl>
<dt>a. </dt>
<dd>the existing certificate can no longer be used for technical reasons or if its continued use is placed in doubt; or</dd>
<dt>b. </dt>
<dd>the existing certificate issued on the basis of an earlier version of this Ordinance certifies a vaccination or recovery that also entitles the holder to a certificate in accordance with the applicable law.</dd>
</dl>
<p><sup>2</sup> Only Swiss COVID-19 certificates that have not been revoked may be exchanged.</p>
<p><sup>3</sup> The application for the automated issuing of a new certificate shall be submitted via the storage app (Art. 28).</p>
<p><sup>4</sup> If the existing certificate meets the requirements of paragraphs 1 and 2, the system for issuing COVID-19-certificates (Art. 26) shall generate a new certificate for the same vaccination or recovery and send the same to the storage app.</p>
<div class="footnotes"><p id="fn-d6e669"><sup><a href="#fnbck-d6e669">22</a></sup> Inserted by No I of the O of 10 June 2022, in force since 27 June 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/374" target="_blank">AS <b>2022</b> 374</a>).</p></div>
</div></article><article id="art_9"><a name="a9"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_9"><b>Art. 9</b> <b></b>Form of the COVID-19 certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The requesting person may choose to have the COVID-19 certificate issued in hard copy or electronic format.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The COVID-19 certificates bear a regulated electronic seal of the Federal Office of Public Health (FOPH) as the means of verification of the authenticity and integrity of the information.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> Both forms of certificate display the content as a human-readable text and two-dimensional machine-readable code (barcode). However, the barcode and the data stored in it in sealed electronic format are also considered to be a certificate.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>4</sup> Certificates are issued in an official language of the Confederation as chosen by the requesting person and in English.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>5</sup> They contain a unique certificate identifier.</p>
</div></article><article id="art_10"><a name="a10"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_10"><b>Art. 10</b> Revocation of COVID-19 certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The issuers specified in Articles 6 and 7 and the competent cantonal authorities shall revoke a COVID-19 certificate at the request of the holder if the holder credibly demonstrates that:</p>
<dl>
<dt>a. </dt>
<dd>the certificate contains incorrect information; or</dd>
<dt>b. </dt>
<dd>errors have repeatedly occurred when verifying the authenticity, validity or integrity of the certificate.</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> A revocation request must contain the following:</p>
<dl>
<dt>a. </dt>
<dd>the unique certificate identifier;</dd>
<dt>b. </dt>
<dd>information on the identity of the holder, insofar as is necessary to assess the grounds for revocation in accordance with paragraph 1, as well as the further details required to assess the grounds for revocation.</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> Even in the absence of a request, issuers are obliged without delay to revoke the certificates they have issued which do not meet the requirements of this Ordinance or which attest to facts which turn out to be incorrect.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>4</sup> The FOITT and the competent cantonal authorities shall revoke certificates in the issuer's place if the issuer fails to do so within a reasonable period in accordance with paragraphs 1 or 3.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>5</sup> Issuers, the FOITT and the competent cantonal authorities shall revoke certificates in the system for issuing COVID-19 certificates (Art. 26), which shall transmit the identifiers of the revoked certificates to the system for retrieving revoked certificates (Art. 27).</p>
<p><sup>6</sup> Issuers, the FOITT and the competent cantonal authorities shall document the revocation of certificates with the following information:</p>
<dl>
<dt>a. </dt>
<dd>the unique certificate identifier;</dd>
<dt>b. </dt>
<dd>information that makes it clear why the decision to revoke the certificate was made.<sup><a href="#fn-d6e809" id="fnbck-d6e809">23</a></sup>
</dd>
</dl>
<div class="footnotes"><p id="fn-d6e809"><sup><a href="#fnbck-d6e809">23</a></sup> Inserted by No I of the O of 17 Sept. 2021, in force since 20 Sept. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/564" target="_blank">AS <b>2021</b> 564</a>).</p></div>
</div></article><article id="art_11"><a name="a11"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_11"><b>Art. 11</b></a><sup><a href="#fn-d6e823" id="fnbck-d6e823">24</a></sup><a href="#art_11">  Free of charge </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The requesting person shall not be charged for the issuance or revocation of COVID-19 certificates other than in the cases specified in paragraph 2.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The cantons may make provision for issuers to charge an appropriate share of the cost in the following cases:</p>
<dl>
<dt>a. </dt>
<dd>when a certificate has to be reissued repeatedly due to loss;</dd>
<dt>b. </dt>
<dd>when issuing a certificate to persons under Article 7 paragraph 1 letter b who are not permanently or habitually resident in the canton concerned or to Swiss citizens living abroad whose last place of residence or commune of origin is not in the canton concerned.</dd>
</dl>
<p><sup>3</sup> Paragraph 2 letter b does not apply when the canton has ordered isolation.</p>
<div class="footnotes"><p id="fn-d6e823"><sup><a href="#fnbck-d6e823">24</a></sup> Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p></div>
</div></article>
</div></section><section id="sec_3"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_3">Section 3  General Content of All COVID-19 Certificates </a>
</h1>
<div class="collapseable"> <article id="art_12"><a name="a12"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_12"><b>Art. 12</b> </a>
</h6>
<div class="collapseable">
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> All COVID-19 certificates shall contain the following information in accordance with Annex 1:</p>
<dl>
<dt>a. </dt>
<dd>details of the identity of the holder;</dd>
<dt>b. </dt>
<dd>details of the electronic seal issuer;</dd>
<dt>c.<sup><a href="#fn-d6e889" id="fnbck-d6e889">25</a></sup> </dt>
<dd>...</dd>
</dl>
<p><sup>2</sup> COVID-19 certificates in human-readable form shall also contain a general statement on the meaning of the certificate in accordance with Annex 1 number 3.<sup><a href="#fn-d6e906" id="fnbck-d6e906">26</a></sup> </p>
<div class="footnotes">
<p id="fn-d6e889"><sup><a href="#fnbck-d6e889">25</a></sup> Repealed by No I of the O of 3 Nov. 2021, with effect from 16 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>).</p>
<p id="fn-d6e906"><sup><a href="#fnbck-d6e906">26</a></sup> Inserted by No I of the O of 3 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>). Amended by No I of the O of  16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since  17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
</div>
</div></article>
</div></section><section id="sec_4"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_4">Section 4  COVID-19 Vaccination Certificates </a>
</h1>
<div class="collapseable"> <article id="art_13"><a name="a13"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_13"><b>Art. 13</b> Requirements </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> A COVID-19 vaccination certificate shall be issued for vaccines that:</p>
<dl>
<dt>a. </dt>
<dd>are authorised in Switzerland;</dd>
<dt>b. </dt>
<dd>are authorised by the European Medicines Agency for the EU in accordance with Regulation (EC) No 726/2004<sup><a href="#fn-d6e950" id="fnbck-d6e950">27</a></sup>;</dd>
<dt>c. </dt>
<dd>are authorised in accordance with the WHO Emergency Use Listing; or</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">d. can be shown to have the same composition as a vaccine authorised in accordance with letters a, b or c, but which is marketed by the licence holder under another name (licensed products).<sup><a href="#fn-d6e968" id="fnbck-d6e968">28</a></sup></p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> A COVID-19 vaccination certificate shall be issued for each dose:</p>
<dl>
<dt>a. </dt>
<dd>at the time of vaccination;</dd>
<dt>b. </dt>
<dd>subsequent to the vaccination if the administration of the vaccine, including the information in accordance with Article 14, is evident from the medical history or primary documentation that the issuer has on the person requesting the certificate;</dd>
<dt>c. </dt>
<dd>subsequent to the vaccination if no medical history or primary documentation is available and the administration of the vaccine, including the information in accordance with Article 14, can be reliably established from one of the following supporting documents:<dl>
<dt>1. </dt>
<dd>an international certificate of vaccination in accordance with the model in Annex 6 to the International Health Regulations (2005) of 23 May 2005<sup><sup><a href="#fn-d6e1005" id="fnbck-d6e1005">29</a></sup></sup>, indicating the vaccine administered and bearing the signature and stamp of the body responsible,</dd>
<dt>2. </dt>
<dd>confirmation of vaccination issued by a cantonal vaccination centre,</dd>
<dt>3. </dt>
<dd>a vaccination record indicating the vaccine administered and bearing the signature or stamp of the body responsible in Switzerland,</dd>
<dt>4. </dt>
<dd>any other Swiss or foreign document equivalent to one of the documents mentioned in numbers 1 to 3.</dd>
</dl>
</dd>
</dl>
<p><sup>2bis</sup> ...<sup><a href="#fn-d6e1033" id="fnbck-d6e1033">30</a></sup></p>
<p><sup>2ter</sup> In the case of vaccines and their licensed products that are neither authorised for Switzerland nor for the EU but which are permitted under the WHO Emergency Use Listing, a certificate may be issued provided the person concerned attends in person at the issuer's office.<sup><a href="#fn-d6e1053" id="fnbck-d6e1053">31</a></sup></p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> COVID-19 certificates in accordance with paragraph 2 letter c may only be issued by the issuers specified in Article 7 if the person concerned has been vaccinated in full in accordance with Annex 2 number 3.<sup><a href="#fn-d6e1073" id="fnbck-d6e1073">32</a></sup></p>
<div class="footnotes">
<p id="fn-d6e950"><sup><a href="#fnbck-d6e950">27</a></sup>  Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, OJ L 136, <i>30.4.2004</i>, p. 1; last amended by Regulation (EU) No 2019/5, OJ L 4, <i>7.1.2018</i>, p. 24.</p>
<p id="fn-d6e968"><sup><a href="#fnbck-d6e968">28</a></sup> Amended by No I of the O of 17 Sept. 2021, in force since 20 Sept. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/564" target="_blank">AS <b>2021</b> 564</a>).</p>
<p id="fn-d6e1005"><sup><a href="#fnbck-d6e1005">29</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2007/343" target="_blank">SR <b>0.818.103</b></a></p>
<p id="fn-d6e1033"><sup><a href="#fnbck-d6e1033">30</a></sup> Inserted by No I of the O of 17 Sept. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/564" target="_blank">AS <b>2021</b> 564</a>). Repealed by No I of the O of  3 Nov. 2021, with effect from 16 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>).</p>
<p id="fn-d6e1053"><sup><a href="#fnbck-d6e1053">31</a></sup> Inserted by No I of the O of 17 Sept. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/564" target="_blank">AS <b>2021</b> 564</a>). Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e1073"><sup><a href="#fnbck-d6e1073">32</a></sup> Amended by No I of the O of 3 Nov. 2021, in force since 16 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>).</p>
</div>
</div></article><article id="art_14"><a name="a14"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_14"><b>Art. 14</b></a><sup><a href="#fn-d6e1087" id="fnbck-d6e1087">33</a></sup><a href="#art_14"> Content </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">In addition to the general content of all COVID-19 certificates, COVID-19 vaccination certificates shall contain the details in accordance with Annex 2 on the COVID-19 vaccination carried out, and in particular whether the vaccine has been administered in full.</p>
<div class="footnotes"><p id="fn-d6e1087"><sup><a href="#fnbck-d6e1087">33</a></sup> Amended by No I of the O of 30 June 2021, in force since 3 July 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/410" target="_blank">AS <b>2021</b> 410</a>).</p></div>
</div></article><article id="art_15"><a name="a15"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_15"><b>Art. 15</b> Validity </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The start and duration of the validity of COVID-19 vaccination certificates are governed by Annex 2.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The period of validity begins at the earliest on the day on which the final dose is administered, provided the vaccine is administered in full in accordance with the requirements of Annex 2.<sup><a href="#fn-d6e1119" id="fnbck-d6e1119">34</a></sup></p>
<p><sup>3</sup> ...<sup><a href="#fn-d6e1133" id="fnbck-d6e1133">35</a></sup></p>
<div class="footnotes">
<p id="fn-d6e1119"><sup><a href="#fnbck-d6e1119">34</a></sup> Amended by No I of the O of 30 June 2021, in force since 3 July 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/410" target="_blank">AS <b>2021</b> 410</a>).</p>
<p id="fn-d6e1133"><sup><a href="#fnbck-d6e1133">35</a></sup> Inserted by No I of the O of 3 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>). Repealed by No I of the O of  16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), with effect from 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
</div>
</div></article>
</div></section><section id="sec_5"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_5">Section 5  COVID-19 Recovery Certificates </a>
</h1>
<div class="collapseable"> <article id="art_16"><a name="a16"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_16"><b>Art. 16</b></a><sup><a href="#fn-d6e1157" id="fnbck-d6e1157">36</a></sup><a href="#art_16">  Requirements </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> A COVID-19 recovery certificate shall be issued when a person has been infected with Sars-CoV-2 and has recovered. The finding that the person has been infected with the virus must be based on the positive result from the following analyses:</p>
<dl>
<dt>a. </dt>
<dd>a molecular-biological analysis for Sars-CoV-2;</dd>
<dt>b. </dt>
<dd>a Sars-CoV-2 rapid test for specialist use pursuant to Article 24<i>a</i> paragraph 1 of the COVID-19 Ordinance 3 of 19 June 2020<sup><a href="#fn-d6e1189" id="fnbck-d6e1189">37</a></sup>, provided:<dl>
<dt>1. </dt>
<dd>the sample was taken on or after 1 October 2021 in Switzerland by a facility specified in Annex 6 number 1.4.3 letter a of the COVID-19 Ordinance 3, and</dd>
<dt>2. </dt>
<dd>the test is not based on a sample taken solely from the nasal cavity or on a saliva sample;</dd>
</dl>
</dd>
<dt>c. </dt>
<dd>a laboratory immunological analysis for Sars-CoV-2 antigens, provided:<dl>
<dt>1. </dt>
<dd>the analysis was carried out by a laboratory licensed under Article 16 of the Epidemics Act of 28 September 2012<sup><a href="#fn-d6e1220" id="fnbck-d6e1220">38</a></sup>,</dd>
<dt>2. </dt>
<dd>the analysis is authorised in the EU for issuing an EU digital COVID certificate,</dd>
<dt>3. </dt>
<dd>the sample was taken on or after 1 October 2021 in Switzerland by a facility specified in Annex 6 number 1.4.3 letter a of the COVID-19 Ordinance 3, and</dd>
<dt>4. </dt>
<dd>the analysis is not based on a sample taken solely from the nasal cavity or on a saliva sample.<sup><a href="#fn-d6e1244" id="fnbck-d6e1244">39</a></sup>
</dd>
</dl>
</dd>
</dl>
<p><sup>2</sup> A request to be issued with a COVID-19 recovery certificate for an infection from which the person concerned has recovered while abroad must be based on a positive molecular-biological analysis for Sars-CoV-2 and be accompanied by the following documents:<sup><a href="#fn-d6e1258" id="fnbck-d6e1258">40</a></sup></p>
<dl>
<dt>a. </dt>
<dd>proof of a positive molecular-biological analysis for Sars-CoV-2 in accordance with paragraph 1 that includes the following information:<dl>
<dt>1. </dt>
<dd>the requesting person's surname, first name and date of birth,</dd>
<dt>2. </dt>
<dd>the date and time at which the sample was taken,</dd>
<dt>3. </dt>
<dd>the name and address of the test centre or the institution where the test was carried out;</dd>
</dl>
</dd>
<dt>b. </dt>
<dd>confirmation of termination of isolation or a medical certificate confirming recovery from a competent authority with official duties, including the name and address of this authority.</dd>
</dl>
<div class="footnotes">
<p id="fn-d6e1157"><sup><a href="#fnbck-d6e1157">36</a></sup> Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e1189"><sup><a href="#fnbck-d6e1189">37</a></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2020/438" target="_blank">SR <b>818.101.24</b></a></p>
<p id="fn-d6e1220"><sup><a href="#fnbck-d6e1220">38</a></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2015/297" target="_blank">SR <b>818.101</b></a></p>
<p id="fn-d6e1244"><sup><a href="#fnbck-d6e1244">39</a></sup> Amended by No I of the O of 27 April 2022 (EU Compatible COVID-19 Recovery Certificates for Rapid Antigen Tests), in force since 2 May 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/258" target="_blank">AS <b>2022</b> 258</a>).</p>
<p id="fn-d6e1258"><sup><a href="#fnbck-d6e1258">40</a></sup> Amended by No I of the O of 27 April 2022 (EU Compatible COVID-19 Recovery Certificates for Rapid Antigen Tests), in force since 2 May 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/258" target="_blank">AS <b>2022</b> 258</a>).</p>
</div>
</div></article><article id="art_17"><a name="a17"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_17"><b>Art. 17</b></a><sup><a href="#fn-d6e1299" id="fnbck-d6e1299">41</a></sup><a href="#art_17">  Content </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">In addition to the general content of all COVID-19 certificates, COVID-19 recovery certificates shall specify that the holder contracted COVID-19 or tested positive for COVID-19 antibodies, as well as the dates on which the samples were taken and the analyses in accordance with Annex 3 number 2 were carried out.</p>
<div class="footnotes"><p id="fn-d6e1299"><sup><a href="#fnbck-d6e1299">41</a></sup> Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p></div>
</div></article><article id="art_18"><a name="a18"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_18"><b>Art. 18</b> Validity </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The start and duration of the validity of COVID-19 recovery certificates are governed by Annex 3.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> A COVID-19 recovery certificate pursuant to Article 16 paragraph 1 shall be valid at the earliest from the eleventh day after infection was confirmed.<sup><a href="#fn-d6e1331" id="fnbck-d6e1331">42</a></sup></p>
<p><sup>3 </sup>and<sup> 4</sup> …<sup><a href="#fn-d6e1348" id="fnbck-d6e1348">43</a></sup> </p>
<p><sup>5</sup> COVID-19 recovery certificates pursuant to Article 16 paragraph 1 shall contain an expiry date that is compatible with the requirements of Regulation (EU) 2021/953<sup><a href="#fn-d6e1369" id="fnbck-d6e1369">44</a></sup>. Under Annex 3 number 1.2 letter a, they may remain valid beyond the date specified.<sup><a href="#fn-d6e1374" id="fnbck-d6e1374">45</a></sup></p>
<div class="footnotes">
<p id="fn-d6e1331"><sup><a href="#fnbck-d6e1331">42</a></sup> Amended by No I of the O of 19 Jan. 2022 (COVID Recovery Certificates for Rapid Antigen Tests), in force since 24 Jan. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/20" target="_blank">AS <b>2022</b> 20</a>).</p>
<p id="fn-d6e1348"><sup><a href="#fnbck-d6e1348">43</a></sup> Inserted by No I of the O of 3 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>). Repealed by No I of the O of  16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), with effect from 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e1369"><sup><a href="#fnbck-d6e1369">44</a></sup>  Regulation (EU) 2021/953 of the European Parliament and of the Council of  14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic. Version in OJ L 211 of 15.6.2021, p. 1; amended by Regulation (EU) 2022/1034, OJ L 173 of 30.6.2022, p. 37.</p>
<p id="fn-d6e1374"><sup><a href="#fnbck-d6e1374">45</a></sup> Inserted by No I of the O of 3 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>). Amended by No I of the O of  10 June 2022, in force since 1 July. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/374" target="_blank">AS <b>2022</b> 374</a>,<a href="https://fedlex.data.admin.ch/eli/oc/2022/382" target="_blank">382</a>).</p>
</div>
</div></article>
</div></section><section id="sec_6"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_6">Section 6  COVID-19 Test Certificates </a>
</h1>
<div class="collapseable"> <article id="art_19"><a name="a19"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_19"><b>Art. 19</b> Requirements </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> A COVID-19 test certificate shall be issued in the event of a negative result of:</p>
<dl>
<dt>a. </dt>
<dd>a molecular-biological analysis for Sars-CoV-2;</dd>
<dt>b.<sup><a href="#fn-d6e1418" id="fnbck-d6e1418">46</a></sup> </dt>
<dd>a Sars-CoV-2 rapid test for specialist use in accordance with Article 24<i>a</i> of the COVID-19 Ordinance 3 of 19 June 2020<sup><a href="#fn-d6e1434" id="fnbck-d6e1434">47</a></sup>, unless it is based on a sample taken only from the nasal cavity or on a saliva sample.</dd>
<dt>c.<sup><a href="#fn-d6e1446" id="fnbck-d6e1446">48</a></sup> </dt>
<dd>a laboratory immunological analysis for Sars-CoV-2 antigens, provided: <dl>
<dt>1. </dt>
<dd>the analysis was carried out by a laboratory licensed under Article 16 of the Epidemics Act of 28 September 2012<sup><a href="#fn-d6e1465" id="fnbck-d6e1465">49</a></sup>,</dd>
<dt>2. </dt>
<dd>the test is authorised in the EU for issuing an EU digital COVID certificate,</dd>
<dt>3. </dt>
<dd>the sample was taken by a facility specified in Annex 6 number 1.4.3 letter a of the COVID-19 Ordinance 3, and</dd>
<dt>4. </dt>
<dd>the test is not based on a sample taken solely from the nasal cavity or on a saliva sample.</dd>
</dl>
</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1bis</sup> The FOPH shall maintain an updated list of Sars-CoV-2 rapid tests in accordance with paragraph 1 letter b of laboratory immunological analyses for Sars-CoV-2 antigens in accordance with paragraph 1 letter c, and publish it on its website.<sup><a href="#fn-d6e1493" id="fnbck-d6e1493">50</a></sup></p>
<p><sup>1ter</sup> COVID-19 test certificates may not be issued for analyses for Sars-CoV-2 in the following cases: </p>
<dl>
<dt>a. </dt>
<dd>to persons who have symptoms;</dd>
<dt>b. </dt>
<dd>to persons who have in any of the following periods lived in the same household as or in a similar way have had close and regular contact with:<dl>
<dt>1. </dt>
<dd>a person whose infection with Sars-VoV-2 has been confirmed or is probable and who has symptoms: in the 48 hours prior to the appearance of symptoms and for 5 days thereafter,</dd>
<dt>2. </dt>
<dd>a person whose infection with Sars-VoV-2 has been confirmed but who is asymptomatic: in the 48 hours prior to the sample being taken and until the person went into isolation;</dd>
</dl>
</dd>
<dt>c. </dt>
<dd>in an outbreak investigation and control ordered by a doctor;</dd>
<dt>d. </dt>
<dd>to persons who have been notified by the SwissCOVID app that they have potentially had close contact with a person who has been infected with Sars-CoV-2;</dd>
<dt>e. </dt>
<dd>to persons who have tested positive in a Sars-CoV-2 rapid test for specialist use or in a Sars-CoV-2 self-test.<sup><a href="#fn-d6e1550" id="fnbck-d6e1550">51</a></sup>
</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> Requests for test certificates may be submitted <inl>at the latest when the sample is taken</inl>.</p>
<div class="footnotes">
<p id="fn-d6e1418"><sup><a href="#fnbck-d6e1418">46</a></sup> Amended by No I of the O of 3 Nov. 2021, in force since 16 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>).</p>
<p id="fn-d6e1434"><sup><a href="#fnbck-d6e1434">47</a></sup> <a href="https://fedlex.data.admin.ch/eli/cc/2020/438" target="_blank">SR <b>818.101.24</b></a></p>
<p id="fn-d6e1446"><sup><a href="#fnbck-d6e1446">48</a></sup> Inserted by Annex No 3 of the O of 17 Dec. 2021, in force since 18 Dec. 2021  (<a href="https://fedlex.data.admin.ch/eli/oc/2021/881" target="_blank">AS <b>2021</b> 881</a>).</p>
<p id="fn-d6e1465"><sup><a href="#fnbck-d6e1465">49</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2015/297" target="_blank">SR <b>818.101</b></a></p>
<p id="fn-d6e1493"><sup><a href="#fnbck-d6e1493">50</a></sup> Inserted by No I of the O of 30 June 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/410" target="_blank">AS <b>2021</b> 410</a>). Amended by Annex No 3 of the O of 17 Dec. 2021, in force since 18 Dec. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/881" target="_blank">AS <b>2021</b> 881</a>).</p>
<p id="fn-d6e1550"><sup><a href="#fnbck-d6e1550">51</a></sup> Inserted by No IV of the O of 25 Aug. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/507" target="_blank">AS <b>2021</b> 507</a>). Amended by Annex No 2 of the O of 16 Feb. 2022, in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/96" target="_blank">AS <b>2022</b> 96</a>).</p>
</div>
</div></article><article id="art_20"><a name="a20"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_20"><b>Art. 20</b> Content </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">In addition to the general content of all COVID-19 certificates, COVID-19 test certificates shall contain information on the test carried out in accordance with Annex 4.</p>
</div></article><article id="art_21"><a name="a21"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_21"><b>Art. 21</b> Validity </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> COVID-19 test certificates shall be valid from the time they are issued.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The duration of validity is governed by Annex 4.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> It shall be a maximum of 72 hours from the time the sample was taken.</p>
</div></article>
</div></section><section id="sec_6_a"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_6_a">Section 6<i>a</i>  … </a>
</h1>
<div class="collapseable"> <article id="art_21"><a name="ta21"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_21"><b>Art. 21</b><i>a</i><b>–21</b><i>c</i></a><sup><a href="#fn-d6e1620" id="fnbck-d6e1620">52</a></sup><a href="#art_21">  </a>
</h6>
<div class="collapseable"><div class="footnotes"><p id="fn-d6e1620"><sup><a href="#fnbck-d6e1620">52</a></sup> Inserted by No I of the O of 3 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>). Repealed by No I of the O of  16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), with effect from 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p></div></div></article>
</div></section><section id="sec_7"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_7">Section 7  Foreign Certificates </a>
</h1>
<div class="collapseable"> <article id="art_22"><a name="a22"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_22"><b>Art. 22</b> <b></b>Recognition of certificates issued by an EU member state or an EFTA state </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The recognised vaccination, recovery and test certificates issued by a member state of the European Union (EU) or a state of the European Free Trade Association (EFTA) are listed in Annex 5.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The Federal Department of Home Affairs (FDHA) shall update Annex 5 continuously in consultation with the Federal Department of Finance (FDF) and the Federal Department of Foreign Affairs (FDFA).<sup><a href="#fn-d6e1661" id="fnbck-d6e1661">53</a></sup></p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> It shall include in the Annex certificates that were issued in accordance with the provisions applicable in the EU and whose states of origin grant reciprocal rights. However, it may decide not to include certificates for vaccines that are not authorised for the EU by the European Medicines Agency in accordance with Regulation (EC) No. 726/2004<sup><a href="#fn-d6e1675" id="fnbck-d6e1675">54</a></sup>.</p>
<div class="footnotes">
<p id="fn-d6e1661"><sup><a href="#fnbck-d6e1661">53</a></sup> Amended by No I of the O of 1 Sept. 2021, in force since 7 Sept. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/522" target="_blank">AS <b>2021</b> 522</a>).</p>
<p id="fn-d6e1675"><sup><a href="#fnbck-d6e1675">54</a></sup>  Regulation (EC) No. 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, OJ L 136 of 30.04.2004, p. 1; last amended by Regulation (EC) No. 2019/5, OJ L 4 of 7.1.2018, p. 24.</p>
</div>
</div></article><article id="art_23"><a name="a23"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_23"><b>Art. 23</b> <b></b>Recognition of other foreign certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The recognised foreign certificates attesting vaccination, recovery or testing that have not been issued by an EU or EFTA member state are listed in Annex 5.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> As soon as the European Commission makes a decision regarding the equivalence of one or more interoperable certificates from a state or region, the FDHA shall update Annex 5 accordingly. However, it shall only accept certificates from the states and regions listed in Annex 5 that grant Switzerland reciprocal rights.<sup><a href="#fn-d6e1698" id="fnbck-d6e1698">55</a></sup></p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> It may include certificates from other states or regions provided the following requirements are met:<sup><a href="#fn-d6e1712" id="fnbck-d6e1712">56</a></sup></p>
<dl>
<dt>a. </dt>
<dd>The foreign certificate contains the information specified in Article 12 and in Articles 14, 17 or 20 in conjunction with the relevant annexes.</dd>
<dt>b. </dt>
<dd>The information under letter a can be checked electronically for authenticity, integrity and validity.</dd>
<dt>c. </dt>
<dd>Requirements equivalent to those under this Ordinance apply to the issuance of the respective certificates.</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>4</sup> It shall delete those certificates that no longer meet the requirements from the list.</p>
<div class="footnotes">
<p id="fn-d6e1698"><sup><a href="#fnbck-d6e1698">55</a></sup> Amended by No I of the O of 19 Jan. 2022 (COVID Recovery Certificates for Rapid Antigen Tests), in force since 24 Jan. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/20" target="_blank">AS <b>2022</b> 20</a>).</p>
<p id="fn-d6e1712"><sup><a href="#fnbck-d6e1712">56</a></sup> Amended by No I of the O of 19 Jan. 2022 (COVID Recovery Certificates for Rapid Antigen Tests), in force since 24 Jan. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/20" target="_blank">AS <b>2022</b> 20</a>).</p>
</div>
</div></article><article id="art_24"><a name="a24"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_24"><b>Art. 24</b> Significance of recognition </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Recognised foreign certificates shall be equivalent to the COVID-19 certificates issued in accordance with this Ordinance. In particular, the apps for storing and verifying certificates (Arts. 28 and 29) shall treat them as certificates issued in accordance with this Ordinance.</p>
</div></article>
</div></section><section id="sec_8"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_8">Section 8 Federal Information Systems and Software Provided by the Confederation </a>
</h1>
<div class="collapseable">
<br><article id="art_25"><a name="a25"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_25"><b>Art. 25</b> System for managing electronically signed certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The FOITT shall operate an information system that is used to do the following with electronically signed certificates in order to check the authenticity, integrity and validity of electronic signatures of COVID-19 certificates:</p>
<dl>
<dt>a  </dt>
<dd>exchange them with corresponding foreign systems, particularly within the framework of the EU Digital COVID Certificate system of the European Union;</dd>
<dt>b  </dt>
<dd>make them available to the apps that are used to store and verify certificates.</dd>
</dl>
<p><sup>2</sup> ...<sup><a href="#fn-d6e1783" id="fnbck-d6e1783">57</a></sup> </p>
<div class="footnotes"><p id="fn-d6e1783"><sup><a href="#fnbck-d6e1783">57</a></sup> Inserted by No I of the O of 3 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>). Repealed by No I of the O of  16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), with effect from 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p></div>
</div></article><article id="art_26"><a name="a26"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_26"><b>Art. 26</b> System for issuing COVID-19 certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The FOITT shall operate an information system for generating, transmitting and revoking COVID-19 certificates.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The personal data of requesting persons may not be retained for longer than is necessary for generating, signing and transmitting the certificate, or for revoking it.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> In order to detect and prevent misuse and for the purpose of any subsequent revocation of certificates, the system shall log which issuer retrieved which certificates and when.</p>
</div></article><article id="art_26_a"><a name="a26a"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_26_a"><b>Art. 26</b><i>a</i></a><sup><a href="#fn-d6e1826" id="fnbck-d6e1826">58</a></sup><a href="#art_26_a"><i></i> <i></i>System for requesting COVID-19 certificates for vaccination or recovery abroad </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> The FOITT shall operate a system that can be used to submit requests under Article 7 paragraph 1 letter b and by issuers to process these requests.</p>
<p><sup>2</sup> The system shall allocate the requests for the issuance of a certificate to a person resident or with place of origin in Switzerland as follows:</p>
<dl>
<dt>a. </dt>
<dd>in the case of persons resident in Switzerland: to the canton of residence;</dd>
<dt>b. </dt>
<dd>in the case of Swiss citizens living abroad, to the last canton of residence, or, if the person has never been resident in Switzerland, the canton in which the place of origin is located;</dd>
<dt>c. </dt>
<dd>in all other cases: to the canton in which the person was last habitually resident.<sup><a href="#fn-d6e1867" id="fnbck-d6e1867">59</a></sup>
</dd>
</dl>
<p><sup>3</sup> ...<sup><a href="#fn-d6e1881" id="fnbck-d6e1881">60</a></sup> </p>
<p><sup>4</sup> The requests, the documents submitted and the unique certificate identifier shall be retained for 30 days and then deleted from the system.</p>
<div class="footnotes">
<p id="fn-d6e1826"><sup><a href="#fnbck-d6e1826">58</a></sup> Inserted by No I of the O of 1 Oct. 2021, in force since 11 Oct. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/592" target="_blank">AS <b>2021</b> 592</a>).</p>
<p id="fn-d6e1867"><sup><a href="#fnbck-d6e1867">59</a></sup> Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e1881"><sup><a href="#fnbck-d6e1881">60</a></sup> Repealed by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), with effect from 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
</div>
</div></article><article id="art_27"><a name="a27"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_27"><b>Art. 27</b> System for retrieving revoked certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The FOITT shall operate a system that is used to retrieve revoked certificates and contains the unique certificate identifier for this purpose.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The list of revoked certificate identifiers shall be made available to apps used for checking and storing COVID-19 certificates.</p>
</div></article><article id="art_28"><a name="a28"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_28"><b>Art. 28</b> Storage app: General</a><sup><a href="#fn-d6e1917" id="fnbck-d6e1917">61</a></sup><a href="#art_28"> </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The FOITT shall provide software that the holders of COVID-19 certificates can install on their mobile telephones or similar devices and use for the secure transmission and electronic storage of the certificates.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The following principles apply to the software:</p>
<dl>
<dt>a. </dt>
<dd>It may disclose the contents of certificates or make statements about it solely with the holder's consent in the individual case.</dd>
<dt>b. </dt>
<dd>The contents of certificates must be protected against unauthorised access by means of appropriate measures.</dd>
<dt>c. </dt>
<dd>The FOITT shall publish the source code and technical specifications for the software it makes available.</dd>
</dl>
<p><sup>3</sup> The software shall indicate to the holder the access categories in accordance with Annex 6 numbers 1–3 with which their certificate complies.<sup><a href="#fn-d6e1959" id="fnbck-d6e1959">62</a></sup> </p>
<div class="footnotes">
<p id="fn-d6e1917"><sup><a href="#fnbck-d6e1917">61</a></sup>  Amended by No I of the O of 30 June 2021, in force since 12 July 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/410" target="_blank">AS <b>2021</b> 410</a>).</p>
<p id="fn-d6e1959"><sup><a href="#fnbck-d6e1959">62</a></sup> Inserted by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
</div>
</div></article><article id="art_28_a"><a name="a28a"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_28_a"><b>Art. 28</b><i>a</i></a><sup><a href="#fn-d6e1976" id="fnbck-d6e1976">63</a></sup><a href="#art_28_a"><i></i> <i></i>Storage app: Retrieval of certificates with data minimisation </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The app for storing COVID-19 certificates shall enable holders to obtain a certificate with data minimisation for use in Switzerland.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> To do so, the holder uses the app to send a COVID-19 certificate to the system for issuing COVID-19 certificates. If the certificate sent is valid, the system generates the data-minimised certificate and send it to the storage app.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> The certificate with data minimisation contains:</p>
<dl>
<dt>a. </dt>
<dd>the general content in accordance with Article 12 letter a and Annex 1 section 1; </dd>
<dt>b. </dt>
<dd>the designation of Swiss COVID-19 certificate with data minimisation;</dd>
<dt>c. </dt>
<dd>the expiry date.</dd>
</dl>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>4</sup> The period of validity of the certificate with data minimisation shall correspond to the shortest period of validity of COVID-19 test certificates in accordance with Annex 4; however, it shall end in any case when the underlying certificate expires.</p>
<div class="footnotes"><p id="fn-d6e1976"><sup><a href="#fnbck-d6e1976">63</a></sup>  Inserted by No I of the O of 30 June 2021, in force since 12 July 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/410" target="_blank">AS <b>2021</b> 410</a>).</p></div>
</div></article><article id="art_29"><a name="a29"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_29"><b>Art. 29</b> Verification app </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The FOITT shall provide one or more software programs that can be installed on mobile telephones or similar devices and used for the electronic verification of the authenticity, integrity, validity and compliance with the access categories in accordance with Annex 6 of COVID-19 certificates, including certificates with data minimisation, and corresponding foreign certificates.<sup><a href="#fn-d6e2037" id="fnbck-d6e2037">64</a></sup></p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The following principles apply to the software programs:</p>
<dl>
<dt>a. </dt>
<dd>They shall verify the authenticity, integrity and validity of COVID-19 certificates without transmitting or storing personal data.</dd>
<dt>b. </dt>
<dd>They shall verify foreign certificates according to the rules applicable to COVID-19 certificates.</dd>
<dt>c. </dt>
<dd>They shall issue the result of the verification solely in the following form:<dl>
<dt>1.<sup><a href="#fn-d6e2071" id="fnbck-d6e2071">65</a></sup> </dt>
<dd>an indication that verification was successful (green background) or unsuccessful (red background) or not possible (orange background) and, if applicable, information on the reasons for the failure of verification;</dd>
<dt>2.  </dt>
<dd>information in accordance with Annex 1 that allows the certificate to be assigned to the holder;</dd>
<dt>3.<sup><a href="#fn-d6e2092" id="fnbck-d6e2092">66</a></sup> </dt>
<dd>information on the compliance of the certificate with the access categories in accordance with Annex 6.</dd>
</dl>
</dd>
<dt>d. </dt>
<dd>They can verify the authenticity, integrity and validity of the certificates without being connected to the internet at the time of verification; however, the verification of validity requires an updated list from the system for retrieving revoked certificates, which requires an internet connection.</dd>
<dt>e. </dt>
<dd>The FOITT shall publish the source code and technical specifications for the software programs it makes available.</dd>
</dl>
<p><sup>3</sup> Any person who is shown a certificate for verification may not retain it or the information read from it or use it for any purpose other than verification. The foregoing does not apply to storing information on the period of validity of certificates at facilities that may only be accessed by persons who have personal authorisation for repeated access. The data subject must be appropriately informed about the nature and extent of the data processing and must expressly consent to that processing.<sup><a href="#fn-d6e2119" id="fnbck-d6e2119">67</a></sup></p>
<div class="footnotes">
<p id="fn-d6e2037"><sup><a href="#fnbck-d6e2037">64</a></sup>  Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e2071"><sup><a href="#fnbck-d6e2071">65</a></sup> Amended by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e2092"><sup><a href="#fnbck-d6e2092">66</a></sup> Inserted by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e2119"><sup><a href="#fnbck-d6e2119">67</a></sup> Amended by No I of the O of 3 Nov. 2021, in force since 16 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>).</p>
</div>
</div></article><article id="art_30"><a name="a30"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_30"><b>Art. 30</b> Access to the systems for issuing COVID-19 certificates and for retrieving revoked COVID-19 certificates </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> Users shall log on to the system for issuing COVID-19 certificates via the Federal Administration's central access and authorisation system for web applications. The provisions of the Ordinance of 19 October 2016<sup><a href="#fn-d6e2141" id="fnbck-d6e2141">68</a></sup> on Federal Identity Management Systems and Directory Services (IAMO) apply.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> The FOITT may go beyond Article 21 of the IAMO and connect other external IAM systems to the Confederation's IAM systems, provided these allow for secure identification.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>3</sup> It may deny or revoke access especially in the event of concerns about ICT security.</p>
<div class="footnotes"><p id="fn-d6e2141"><sup><a href="#fnbck-d6e2141">68</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2016/610" target="_blank">SR <b>172.010.59</b></a></p></div>
</div></article><article id="art_31"><a name="a31"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_31"><b>Art. 31</b> Federal body responsible </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">The FOITT is the federal body responsible under the data protection legislation for:</p>
<dl>
<dt>a. </dt>
<dd>the implementation of the necessary technical and organisational measures for the systems it operates;</dd>
<dt>b. </dt>
<dd>the apps it makes available.</dd>
</dl>
</div></article><article id="art_32"><a name="a32"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_32"><b>Art. 32</b> Costs of information systems and apps</a><sup><a href="#fn-d6e2185" id="fnbck-d6e2185">69</a></sup><a href="#art_32"> </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>1</sup> The Confederation shall bear the costs of the procurement and operation of the information systems, and of the provision of the apps.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message"><sup>2</sup> It shall not collect any fees for the use of the systems and apps.</p>
<div class="footnotes"><p id="fn-d6e2185"><sup><a href="#fnbck-d6e2185">69</a></sup> Amended by No I of the O of 1 Oct. 2021, in force since 11 Oct. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/592" target="_blank">AS <b>2021</b> 592</a>).</p></div>
</div></article>
</div></section><section id="sec_9"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_9">Section 9 Final Provisions </a>
</h1>
<div class="collapseable"> <article id="art_33"><a name="a33"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_33"><b>Art. 33</b></a><sup><a href="#fn-d6e2215" id="fnbck-d6e2215">70</a></sup><a href="#art_33"> Updating Annexes 1 to 4 </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">In consultation with the FDF and the FDFA, the FDHA shall update Annexes 1 to 4 in accordance with the internationally harmonised standards in order to achieve interoperability with the certificates of as many states and regions as possible and international recognition of the certificates issued in accordance with this Ordinance.</p>
<div class="footnotes"><p id="fn-d6e2215"><sup><a href="#fnbck-d6e2215">70</a></sup> Amended by No I of the O of 19 Jan. 2022 (COVID Recovery Certificates for Rapid Antigen Tests), in force since 24 Jan. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/20" target="_blank">AS <b>2022</b> 20</a>).</p></div>
</div></article><article id="art_34"><a name="a34"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_34"><b>Art. 34</b> Conclusion of international treaties in connection with the development and implementation of the EU Digital COVID Certificate </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">The FDHA shall be responsible for concluding international treaties for the adoption of delegated and implementing acts issued by the European Commission for the development and technical implementation of the EU Digital COVID Certificate.</p>
</div></article><article id="art_34_a"><a name="a34a"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_34_a"><b>Art. </b><b>34</b><i>a</i></a><sup><a href="#fn-d6e2249" id="fnbck-d6e2249">71</a></sup><a href="#art_34_a"><i></i> <i></i>Transitional provision to the Amendment of 16 February 2022 </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> The following certificates retain their current validity:</p>
<dl>
<dt>a. </dt>
<dd>COVID-19 vaccination certificates under Article 15 paragraph 3 in its version of 3 November 2021<sup><a href="#fn-d6e2276" id="fnbck-d6e2276">72</a></sup>;</dd>
<dt>b.<sup><a href="#fn-d6e2289" id="fnbck-d6e2289">73</a></sup> </dt>
<dd>COVID-19 recovery certificates under Article 16 paragraph 1 letter b in its version of 19 January 2022<sup><a href="#fn-d6e2302" id="fnbck-d6e2302">74</a></sup>;</dd>
<dt>c. </dt>
<dd>COVID-19 recovery certificates under Article 16 paragraph 3 in its version of 3 November 2021<sup><a href="#fn-d6e2317" id="fnbck-d6e2317">75</a></sup>;</dd>
<dt>d. </dt>
<dd>COVID-19 exemption certificates under Article 21<i>a</i> in its version of <br>3 November 2021<sup><a href="#fn-d6e2338" id="fnbck-d6e2338">76</a></sup>.</dd>
</dl>
<p><sup>2</sup> No electronically signed certificates shall be delivered to foreign systems under Article 25 letter a for COVID-19-certificates in accordance with paragraph 1; they shall contain a reference to their related limited validity.</p>
<p><sup>3</sup> Requests under the previous law to be issued with a COVID-19 certificate in accordance with paragraph 1 shall be processed until 0.00 on 21 February 2022. No refund of fees shall be made for requests that are submitted via the system in accordance with Article 26<i>a</i>.</p>
<p><sup>4</sup> The provisions of Sections 2 and 8, with the exception of Articles 2, 8 and 11, also apply to COVID-19 certificates in accordance with paragraph 1. </p>
<div class="footnotes">
<p id="fn-d6e2249"><sup><a href="#fnbck-d6e2249">71</a></sup> Inserted by No I of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p>
<p id="fn-d6e2276"><sup><a href="#fnbck-d6e2276">72</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a></p>
<p id="fn-d6e2289"><sup><a href="#fnbck-d6e2289">73</a></sup> Correction of 14 Apr. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/239" target="_blank">AS <b>2022</b> 239</a>).</p>
<p id="fn-d6e2302"><sup><a href="#fnbck-d6e2302">74</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2022/20" target="_blank">AS <b>2022</b> 20</a></p>
<p id="fn-d6e2317"><sup><a href="#fnbck-d6e2317">75</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a></p>
<p id="fn-d6e2338"><sup><a href="#fnbck-d6e2338">76</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>, <a href="https://fedlex.data.admin.ch/eli/oc/2021/813" target="_blank">813</a></p>
</div>
</div></article><article id="art_35"><a name="a35"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_35"><b>Art. 35</b> Commencement </a>
</h6>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">This Ordinance comes into force on 7 June 2021 at 00.00 and applies until 31 December 2022.</p>
</div></article>
</div></section></main><div id="annex">
<section id="annex_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1">Annex 1</a><i><sup><a href="#fn-d6e2381" id="fnbck-d6e2381">77</a></sup></i><a href="#annex_1"> </a>
</h1>
<div class="footnotes"><p id="fn-d6e2381"><sup><a href="#fnbck-d6e2381">77</a></sup> Revised by No II of the O of 30 June 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/410" target="_blank">AS <b>2021</b> 410</a>), of 17 Sept. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/564" target="_blank">AS <b>2021</b> 564</a>), No I of the FDHA O of 29 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/785" target="_blank">AS <b>2021</b> 785</a>) and No II para. 1 of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p></div>
<div class="collapseable">
<p>(Arts 12, 28<i>a</i> para. 3 let. a, 29 para. 2 let. c No 2 and 33)</p>
<section id="annex_1/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1">General content of COVID-19 certificates </a>
</h2>
<div class="collapseable">
<section id="annex_1/lvl_u1/lvl_1"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_1">1 Details of the holder </a>
</h3>
<div class="collapseable"> <dl>
<dt>a. </dt>
<dd>Officially recorded surname and first name(s) (in that order)</dd>
<dt>b. </dt>
<dd>Date of birth</dd>
</dl>
</div></section><section id="annex_1/lvl_u1/lvl_2"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_2">2 Details of the country in which the vaccine was administered or the test was carried out, and details of the electronic seal issuer </a>
</h3>
<div class="collapseable"> <dl>
<dt>a. </dt>
<dd>Country in which the vaccine was administered or the test was carried out or, if this information is not available and the vaccination was administered or the test carried out by an international organisation, an internationally recognised code for this organisation</dd>
<dt>b. </dt>
<dd>Electronic seal issuer (Federal Office of Public Health)</dd>
</dl>
</div></section><section id="annex_1/lvl_u1/lvl_3"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_u1/lvl_3">3 Statement for COVID-19 certificates in a human-readable form </a>
</h3>
<div class="collapseable"> <p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">COVID-19 certificates that are in a human-readable form must contain the following statement:</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">“This certificate is not a travel document.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">The scientific evidence on COVID-19 vaccination, testing and recovery continues to evolve, also in view of new variants of concern of the virus.</p>
<p msg:wcstyle02-2="loose pPr/suppressAutoHyphens" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Before travelling, please check the applicable public health measures and related restrictions applied at the point of destination.”</p>
</div></section>
</div></section>
</div></section><section id="annex_2"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2">Annex 2</a><i><sup><a href="#fn-d6e2464" id="fnbck-d6e2464">78</a></sup></i><a href="#annex_2"> </a>
</h1>
<div class="footnotes"><p id="fn-d6e2464"><sup><a href="#fnbck-d6e2464">78</a></sup> Amended by No I para. 1 of the FDHA O of 1 Feb. 2022 (Level of Basic Immunisation and Booster Vaccination, Recognition of other Vaccines) (<a href="https://fedlex.data.admin.ch/eli/oc/2022/56" target="_blank">AS <b>2022</b> 56</a>). Revised by No II para. 1 of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland) (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>) and No III of the O of 30 March 2022, in force since 1 April 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/206" target="_blank">AS <b>2022</b> 206</a>).</p></div>
<div class="collapseable">
<p>(Arts. 14, 15 and 33)</p>
<section id="annex_2/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1">Special provisions concerning COVID-19 vaccination certificates </a>
</h2>
<div class="collapseable">
<section id="annex_2/lvl_u1/lvl_1"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1/lvl_1">1 Start of validity and maximum duration </a>
</h3>
<div class="collapseable"> <dl>
<dt>1.1 </dt>
<dd>COVID-19 vaccination certificates are valid for 270 days:<dl>
<dt>a. </dt>
<dd>from the administration of the dose that completes the basic immunisation; or </dd>
<dt>b. </dt>
<dd>from the administration of a dose provided after basic immunisation is completed (booster vaccination).</dd>
</dl>
</dd>
<dt>1.2 </dt>
<dd>In the case of basic immunisation with the Janssen COVID-19 vaccine, the period of validity begins on the 22 day after the single dose was administered.</dd>
</dl>
</div></section><section id="annex_2/lvl_u1/lvl_2"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1/lvl_2">2 Information on the vaccine administered </a>
</h3>
<div class="collapseable"> <dl>
<dt>2.1  </dt>
<dd>Disease against which the vaccination was administered (COVID-19)</dd>
<dt>2.2  </dt>
<dd>Vaccination/prophylaxis (type of vaccine/how it works) </dd>
<dt>2.3 </dt>
<dd>Immunologic agent (name of vaccine/product name)</dd>
<dt>2.4  </dt>
<dd>Holder of the vaccine authorisation or, if not indicated for vaccine doses administered abroad, information on the manufacturer </dd>
<dt>2.5  </dt>
<dd>Number of vaccine doses administered in a series and the total number of doses administered</dd>
<dt>2.6  </dt>
<dd>Date on which the final dose was administered</dd>
</dl>
</div></section><section id="annex_2/lvl_u1/lvl_3"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1/lvl_3">3 Information on the level of vaccination </a>
</h3>
<div class="collapseable"> <dl>
<dt>3.1 </dt>
<dd>General provisions</dd>
<dt>3.1.1 </dt>
<dd>An indication of the level of vaccination is provided:<dl>
<dt>a. </dt>
<dd>in the case of full vaccination: by the codes set out in numbers 3.2–3.4, such as “3/3”;</dd>
<dt>b. </dt>
<dd>in the case of incomplete vaccination: according to the "A/B" system, where A stands for the number of vaccine doses received and B for the number of vaccine doses scheduled at the time of receiving the vaccine dose according to the vaccination programme concerned.</dd>
</dl>
</dd>
<dt>3.1.2 </dt>
<dd>A proven infection with Sars-CoV-2 occurring before a vaccine dose is administered for which a certificate is issued is considered equivalent to a vaccine dose. The following requirements apply to proof of infection:<dl>
<dt>a. </dt>
<dd>Proof of infection must be based on one of the following tests:<dl>
<dt>1. </dt>
<dd>the positive result of a molecular-biological analysis for Sars-CoV‑2;</dd>
<dt>2. </dt>
<dd>the positive result of a Sars-CoV-2 rapid test for specialist use pursuant to Article 24<i>a</i> paragraph 1 of the COVID-19 Ordinance 3 of 19 June 2020<sup><a href="#fn-d6e2604" id="fnbck-d6e2604">79</a></sup>;</dd>
<dt>3. </dt>
<dd>a positive analysis for Sars-CoV-2 antibodies.</dd>
</dl>
</dd>
<dt>b. </dt>
<dd>In the cases specified in letter a numbers 1 and 2, at least 28 days must have elapsed between taking the sample and administering the vaccine.</dd>
</dl>
</dd>
<dt>3.1.3 </dt>
<dd>Vaccine doses also count as booster vaccinations if they are administered to immunosuppressed persons outside the vaccination programmes in accordance with this Ordinance in order to achieve effective basic immunisation.</dd>
<dt>3.2 </dt>
<dd>Single-dose vaccines </dd>
<dt>3.2.1 </dt>
<dd>Number 3.2 applies to the following vaccine authorised by Swissmedic:</dd>
</dl>
<p></p>
<div class="table"><table border="1">
<tr>
<th class=" man-text-align-left "><p>Product name(s) </p></th>
<th class=" man-text-align-left "><p>Manufacturer</p></th>
</tr>
<tr>
<td><p>Janssen COVID-19 vaccine </p></td>
<td><p>Johnson&amp;Johnson</p></td>
</tr>
</table></div>
<dl>
<dt>3.2.2  </dt>
<dd>Indication of level of vaccination in the case of basic immunisation:<dl>
<dt>a.  </dt>
<dd>basic immunisation with a single vaccine dose: “1/1”;</dd>
<dt>b. </dt>
<dd>basic immunisation on the continuation of a vaccination programme started with a different vaccine, for example in the case of contraindications: “2/2”.</dd>
</dl>
</dd>
<dt>3.2.3 </dt>
<dd>Indication of level of vaccination in the case of booster vaccinations:<dl>
<dt>a.  </dt>
<dd>booster vaccination following basic immunisation with a single vaccine dose (No 3.2.2 let. a): “2/1” (for further doses: “[2+X]/1”);</dd>
<dt>b. </dt>
<dd>booster vaccination following basic immunisation begun with a different vaccine (No 3.2.2 let. b): “3/3” (for further doses: “[3+X]/[3+X]”).</dd>
</dl>
</dd>
<dt>3.3 </dt>
<dd>Two-dose vaccines</dd>
<dt>3.3.1 </dt>
<dd>Number 3.3 applies to the following vaccines:</dd>
</dl>
<p></p>
<div class="table"><table border="1">
<tr>
<th class=" man-text-align-left "><p>Product name(s)</p></th>
<th class=" man-text-align-left "><p>Manufacturer</p></th>
</tr>
<tr>
<td><p>Comirnaty (BNT162b2)</p></td>
<td><p>Pfizer/BioNTech</p></td>
</tr>
<tr>
<td><p>Spikevax (mRNA-1273)</p></td>
<td><p>Moderna</p></td>
</tr>
<tr>
<td><p>Vaxzevria (ChAdOx1 nCoV-19)</p></td>
<td><p>AstraZeneca</p></td>
</tr>
<tr>
<td><p>Nuvaxovid (NVX-CoV2373)</p></td>
<td><p>Novavax</p></td>
</tr>
<tr>
<td><p>BIBP P-CoV</p></td>
<td><p>Sinopharm Wuhan /Sinopharm Beijing</p></td>
</tr>
<tr>
<td><p>CoronaVac</p></td>
<td><p>Sinovac</p></td>
</tr>
<tr>
<td><p>Bharat Biotech Covaxin</p></td>
<td><p>Indian Council for Medical Research</p></td>
</tr>
</table></div>
<dl>
<dt>3.3.2 </dt>
<dd>Indication of level of vaccination in the case of basic immunisation:<dl>
<dt>a.  </dt>
<dd>basic immunisation with two vaccine doses: “2/2”; </dd>
<dt>b. </dt>
<dd>basic immunisation through the combination of a single vaccine dose with an earlier infection with Sars-Cov-2 (No 3.1.2): “1/1”.</dd>
</dl>
</dd>
<dt>3.3.3 </dt>
<dd>Indication of level of vaccination in the case of booster vaccinations:<dl>
<dt>a.  </dt>
<dd>booster vaccination following basic immunisation with two vaccine doses (No 3.3.2 let. a): “3/3” (for further doses: “[3+X]/[3+X]”);</dd>
<dt>b. </dt>
<dd>booster vaccination following basic immunisation through the combination of a single vaccine dose with an earlier infection in accordance with No 3.3.2 let. b: “2/1” (for further doses: “[2+X]/1”).</dd>
</dl>
</dd>
<dt>3.4 </dt>
<dd>Supplementing vaccinations with unrecognised vaccines</dd>
<dt>3.4.1 </dt>
<dd>Number 3.4 applies to vaccinations with the following vaccines that do not meet the requirements of Article 13 paragraph 1, but which may be used to supplement a vaccine authorised in Switzerland: </dd>
</dl>
<p></p>
<div class="table"><table border="1">
<tr>
<th class=" man-text-align-left "><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Product name(s)</p></th>
<th class=" man-text-align-left "><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Manufacturer</p></th>
<th class=" man-text-align-left "><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Supplement with a vaccine authorised in Switzerland</p></th>
</tr>
<tr>
<td><p msg:wcstyle02-3="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Sputnik light</p></td>
<td><p msg:wcstyle02-3="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Gamaleya National Centre of Epidemiology and Microbiology</p></td>
<td><p msg:wcstyle02-3="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least one dose has already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-3="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Sputnik V (Gam-COVID-Vac, rAd26-S, rAd5-S)</p></td>
<td><p msg:wcstyle02-3="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Gamaleya National Centre of Epidemiology and Microbiology</p></td>
<td><p msg:wcstyle02-3="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least one dose has already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">KoviVac</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Chumakov Center</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least two doses have already been administered </p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">QazVac (QazCOVID-in)</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Kazakhstan RIBSP</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least two doses have already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Medigen (MVC-COV1901)</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Medigen Vaccine Biologics</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least two doses have already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">SARS-CoV-2 Vaccine (KCONVAC)</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Minhai Biotechnology </p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least two doses have already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">EpiVacCorona</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">VECTOR</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least two doses have already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">SoberanaPlus (Plus CIGB-66)</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Center for Genetic Engineering and Biotechnology</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least one dose has already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">RBD-Dimer, Zifivax (ZF2001)</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Anhui Zhifei Longcom</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least two doses have already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Abadala (CIGB-66)</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Center for Genetic Engineering and Biotechnology</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least two doses have already been administered</p></td>
</tr>
<tr>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">ZyCoV-D</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Zydus Cadila</p></td>
<td><p msg:wcstyle02-2="loose pPr/suppressOverlap" xmlns:msg="urn:com:c-moria:legi4ch:xslt:message">Single dose of Comirnaty (BNT162b2) or Spikevax (mRNA-1273), if at least two doses have already been administered</p></td>
</tr>
</table></div>
<dl>
<dt>3.4.2  </dt>
<dd>Indication of level of vaccination if supplemented with a vaccine authorised in Switzerland: “1/1”.</dd>
<dt>3.4.3 </dt>
<dd>Indication of level of vaccination if a further dose is administered following a supplement in accordance with Number 3.4.2: “2/1” (for further doses: “[2+X]/1”).</dd>
<dt>3.5 </dt>
<dd>Combinations of vaccines (heterologous vaccinations)</dd>
<dt>3.5.1 </dt>
<dd>Vaccines that are authorised in Switzerland or are authorised by the European Medicines Agency for the EU in accordance with Regulation (EC) No 726/2004<sup><a href="#fn-d6e2942" id="fnbck-d6e2942">80</a></sup> may be combined freely with each other for the purpose of basic immunisation.</dd>
<dt>3.5.2 </dt>
<dd>The vaccines in accordance with numbers 3.2 and 3.3 may be combined with any basic immunisation as a booster vaccination. This also applies to combinations with vaccination supplemented in accordance with Number 3.4.</dd>
<dt>3.6 </dt>
<dd>Recognised licensed products</dd>
</dl>
<p>Proof in accordance with Article 13 paragraph 1 letter d is considered to be provided for the following licensed vaccine products:</p>
<p></p>
<div class="table"><table border="1">
<tr>
<th class=" man-text-align-left "><p>Name(s) of the licensed product</p></th>
<th class=" man-text-align-left "><p>Manufacturer of the licensed product</p></th>
<th class=" man-text-align-left "><p>Corresponds to</p></th>
</tr>
<tr>
<td><p>Covishield (ChAdOx1_nCoV-19)</p></td>
<td><p>Serum Institute of India</p></td>
<td><p>Vaxzevria (ChAdOx1 nCoV-19)</p></td>
</tr>
<tr>
<td><p>COVID-19 vaccine <br>recombinant</p></td>
<td><p>Fundação Instituto Oswaldo Cruz (FIOCRUZ) </p></td>
<td><p></p></td>
</tr>
<tr>
<td><p>R-Covi</p></td>
<td><p>R-Pharma CJSC</p></td>
<td><p></p></td>
</tr>
<tr>
<td><p></p></td>
<td><p></p></td>
<td><p></p></td>
</tr>
<tr>
<td><p>Covovax (NXV-CoV2373)</p></td>
<td><p>Serum Institute of India</p></td>
<td><p>Nuvaxovid (NVX-CoV2373)</p></td>
</tr>
</table></div>
<div class="footnotes">
<p id="fn-d6e2604"><sup><a href="#fnbck-d6e2604">79</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2020/438" target="_blank">SR <b>818.101.24</b></a></p>
<p id="fn-d6e2942"><sup><a href="#fnbck-d6e2942">80</a></sup>  Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, OJ L 136, <i>30.4.2004</i>, p. 1; last amended by Regulation (EU) No 2019/5, OJ L 4, <i>7.1.2019</i>, p. 24.</p>
</div>
</div></section>
</div></section>
</div></section><section id="annex_3"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_3">Annex 3</a><i><sup><a href="#fn-d6e3028" id="fnbck-d6e3028">81</a></sup></i><a href="#annex_3"> </a>
</h1>
<div class="footnotes"><p id="fn-d6e3028"><sup><a href="#fnbck-d6e3028">81</a></sup> Amended by No II para. 2 of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland) (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>). Revised by Annex No 2 of the O of 18 March 2022, in force since 21 March 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/182" target="_blank">AS <b>2022</b> 182</a>).</p></div>
<div class="collapseable">
<p>(Arts. 17, 18 paras. 1 and 5 and 33)</p>
<section id="annex_3/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_3/lvl_u1">Special provisions concerning COVID-19 recovery certificates </a>
</h2>
<div class="collapseable">
<section id="annex_3/lvl_u1/lvl_1"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_3/lvl_u1/lvl_1">1 Start of validity and duration </a>
</h3>
<div class="collapseable"> <dl>
<dt>1.1 </dt>
<dd>Start of validity: on the 11th day after the first positive result.</dd>
<dt>1.2 </dt>
<dd>Period of validity: 180 days from the date of the positive result referred to in number 1.1.</dd>
</dl>
</div></section><section id="annex_3/lvl_u1/lvl_2"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_3/lvl_u1/lvl_2">2 Details on the disease and the date of recovery </a>
</h3>
<div class="collapseable"> <dl>
<dt>2.1 </dt>
<dd>Disease from which the holder has recovered (COVID-19).</dd>
<dt>2.2 </dt>
<dd>Date of the first positive result.</dd>
<dt>2.3 </dt>
<dd>Start of validity.</dd>
<dt>2.4 </dt>
<dd>End of validity.</dd>
</dl>
</div></section>
</div></section>
</div></section><section id="annex_4"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_4">Annex 4</a><i><sup><a href="#fn-d6e3094" id="fnbck-d6e3094">82</a></sup></i><a href="#annex_4"> </a>
</h1>
<div class="footnotes"><p id="fn-d6e3094"><sup><a href="#fnbck-d6e3094">82</a></sup> Revised by No II of the O of 30 June 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/410" target="_blank">AS <b>2021</b> 410</a>), Annex No 3 of the O of  17 Dec. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/881" target="_blank">AS <b>2021</b> 881</a>) and No II para. 1 of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), in force since 17 Feb. 2022  (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p></div>
<div class="collapseable">
<p>(Arts. 20, 21 para. 2, 28<i>a</i> para. 4 and 33)</p>
<section id="annex_4/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_4/lvl_u1">Special provisions concerning COVID-19 test certificates </a>
</h2>
<div class="collapseable">
<section id="annex_4/lvl_u1/lvl_1"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_4/lvl_u1/lvl_1">1 ... </a>
</h3>
<div class="collapseable"> </div></section><section id="annex_4/lvl_u1/lvl_2"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_4/lvl_u1/lvl_2">2 Duration of validity </a>
</h3>
<div class="collapseable"> <dl>
<dt>The duration is calculated from the time the sample is taken and is as follows:</dt>
<dd><dl>
<dt>a.  </dt>
<dd>for PCR tests: 72 hours;</dd>
<dt>b. </dt>
<dd>for Sars-CoV-2 rapid tests for specialist use: 24 hours;</dd>
<dt>c. </dt>
<dd>for laboratory immunological analyses for Sars-CoV-2 antigens: 24 hours.</dd>
</dl></dd>
</dl>
</div></section><section id="annex_4/lvl_u1/lvl_3"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_4/lvl_u1/lvl_3">3 Details of the test carried out </a>
</h3>
<div class="collapseable"> <dl>
<dt>a.  </dt>
<dd>Disease tested for (COVID-19)</dd>
<dt>b.  </dt>
<dd>Type of test (PCR or Sars-CoV-2 rapid test or laboratory immunological analysis for Sars-CoV-2 antigens)</dd>
<dt>c.  </dt>
<dd>Name of the test (if Sars-CoV-2 rapid test or laboratory immunological analysis for Sars-CoV-2 antigens)</dd>
<dt>d.  </dt>
<dd>Manufacturer of the test (if Sars-CoV-2 rapid test or laboratory immunological analysis for Sars-CoV-2 antigens)</dd>
<dt>e.  </dt>
<dd>Date and time of the test sample collection</dd>
<dt>f.  </dt>
<dd>Test result (negative)</dd>
<dt>g. </dt>
<dd>Test centre or institution where the test was carried out</dd>
</dl>
</div></section>
</div></section>
</div></section><section id="annex_4_a"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_4_a">Annex 4a</a><i><sup><a href="#fn-d6e3197" id="fnbck-d6e3197">83</a></sup></i><a href="#annex_4_a"> </a>
</h1>
<div class="footnotes"><p id="fn-d6e3197"><sup><a href="#fnbck-d6e3197">83</a></sup> Inserted by No II para. 2 of the O of 3 Nov. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>). Repealed by No II para. 3 of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), with effect from 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p></div>
<div class="collapseable"></div></section><section id="annex_5"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_5">Annex 5</a><i><sup><a href="#fn-d6e3218" id="fnbck-d6e3218">84</a></sup></i><a href="#annex_5"> </a>
</h1>
<div class="footnotes"><p id="fn-d6e3218"><sup><a href="#fnbck-d6e3218">84</a></sup>  Amended by No I of the O of 7 July 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/428" target="_blank">AS <b>2021</b> 428</a>). <inl>Revised by No</inl> II of the O of 17 Sept. 2021 (<a href="https://fedlex.data.admin.ch/eli/oc/2021/564" target="_blank">AS <b>2021</b> 564</a>), of 19 Jan. 2022 (COVID Recovery Certificates for Rapid Antigen Tests) (<a href="https://fedlex.data.admin.ch/eli/oc/2022/20" target="_blank">AS <b>2022</b> 20</a>), of 27 April 2022 (EU Compatible COVID-19 Recovery Certificates for Rapid Antigen Tests) (<a href="https://fedlex.data.admin.ch/eli/oc/2022/258" target="_blank">AS <b>2022</b> 258</a>) and of 10 June 2022, in force since  1 July 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/374" target="_blank">AS <b>2022</b> 374</a>, <a href="https://fedlex.data.admin.ch/eli/oc/2022/382" target="_blank">382</a>).</p></div>
<div class="collapseable">
<p>(Arts. 22, 23 paras. 1 and 2)</p>
<section id="annex_5/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_5/lvl_u1">List of recognised foreign certificates </a>
</h2>
<div class="collapseable"><section id="annex_5/lvl_u1/lvl_1"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_5/lvl_u1/lvl_1">1 Recognised certificates issued by an EU member state or an EFTA state </a>
</h3>
<div class="collapseable"> <dl>
<dt>1.1 </dt>
<dd>Vaccination, recovery and test certificates issued by an EU member state or EFTA state in accordance with Regulation (EU) 2021/953<sup><a href="#fn-d6e3275" id="fnbck-d6e3275">85</a></sup> and the EU legislative acts adopted on the basis thereof are recognised.</dd>
<dt>1.2 </dt>
<dd>Vaccination certificates are recognised only if they have been issued for vaccinations with a vaccine that: <dl>
<dt>a. </dt>
<dd>has authorisation for the EU from the European Medicines Agency; </dd>
<dt>b. </dt>
<dd>is authorised in accordance with the WHO emergency use listing procedure; or</dd>
<dt>c. </dt>
<dd>has been shown to have the same composition as a vaccine licensed under letter a or b but is marketed by a licence holder under a different name and which has been administered in full in accordance with the requirements or recommendations of the country in which the vaccination was carried out.</dd>
</dl>
</dd>
</dl>
<section id="annex_5/lvl_u1/lvl_1/lvl_2"><h4 class="heading" role="heading" aria-level="4">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_5/lvl_u1/lvl_1/lvl_2">2 Other recognised certificates </a>
</h4>
<div class="collapseable"> <dl>
<dt>2.1 </dt>
<dd>Vaccination, recovery and test certificates that are interoperable in accordance with Regulation (EU) 2021/953 and have been issued by the following states and regions are recognised:</dd>
</dl>
<p></p>
<dl>
<dl>
<dt>– </dt>
<dd>Albania</dd>
<dt>– </dt>
<dd>Andorra</dd>
<dt>– </dt>
<dd>Armenia</dd>
<dt>– </dt>
<dd>Benin</dd>
<dt>– </dt>
<dd>Cape Verde</dd>
<dt>– </dt>
<dd>El Salvador</dd>
<dt>– </dt>
<dd>Faroe Islands</dd>
<dt>– </dt>
<dd>Georgia</dd>
<dt>– </dt>
<dd>Holy See (Vatican)</dd>
<dt>– </dt>
<dd>Israel</dd>
<dt>– </dt>
<dd>Morocco</dd>
<dt>– </dt>
<dd>Moldova</dd>
<dt>– </dt>
<dd>Monaco</dd>
<dt>– </dt>
<dd>Montenegro</dd>
<dt>– </dt>
<dd>North Macedonia</dd>
<dt>– </dt>
<dd>Panama</dd>
<dt>– </dt>
<dd>San Marino</dd>
<dt>– </dt>
<dd>Serbia</dd>
<dt>– </dt>
<dd>Seychelles</dd>
<dt>– </dt>
<dd>Thailand</dd>
<dt>– </dt>
<dd>Turkey</dd>
<dt>– </dt>
<dd>Ukraine</dd>
<dt>– </dt>
<dd>United Kingdom</dd>
<dt>– </dt>
<dd>Uruguay</dd>
<dt>– </dt>
<dd>Vietnam</dd>
</dl>
<dt>2.2 </dt>
<dd>Vaccination and test certificates that are interoperable in accordance with Regulation (EU) 2021/953 and have been issued by the following states and regions are recognised:<dl>
<dt>– </dt>
<dd>Malaysia</dd>
<dt>– </dt>
<dd>New Zealand</dd>
<dt>– </dt>
<dd>Singapore</dd>
<dt>– </dt>
<dd>Taiwan (Chinese Taipei)</dd>
<dt>– </dt>
<dd>Togo</dd>
<dt>– </dt>
<dd>United Arab Emirates</dd>
</dl>
</dd>
<dt>2.3 </dt>
<dd>Vaccination certificates that are interoperable in accordance with Regulation (EU) 2021/953 and have been issued by the following states and regions are recognised:<dl>
<dt>– </dt>
<dd>Colombia</dd>
<dt>– </dt>
<dd>Indonesia</dd>
<dt>– </dt>
<dd>Jordan</dd>
<dt>– </dt>
<dd>Lebanon</dd>
<dt>– </dt>
<dd>Tunisia</dd>
</dl>
</dd>
<dt>2.4 </dt>
<dd>Vaccination certificates are only recognised if they have been issued for vaccinations with a vaccine that meets the requirements of number 1.2.</dd>
</dl>
</div></section><div class="footnotes"><p id="fn-d6e3275"><sup><a href="#fnbck-d6e3275">85</a></sup>  Regulation (EU) 2021/953 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic. Version in OJ L 211 of 15.6.2021, p. 1; amended by Regulation (EU) 2022/1034, OJ L 173 of 30.6.2022, p. 37.</p></div>
</div></section></div></section>
</div></section><section id="annex_6"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_6">Annex 6</a><i><sup><a href="#fn-d6e3517" id="fnbck-d6e3517">86</a></sup></i><a href="#annex_6"> </a>
</h1>
<div class="footnotes"><p id="fn-d6e3517"><sup><a href="#fnbck-d6e3517">86</a></sup> Inserted by No II para. 4 of the O of 16 Feb. 2022 (Expiry of COVID-19 Certificates only valid in Switzerland), with effect from 17 Feb. 2022 (<a href="https://fedlex.data.admin.ch/eli/oc/2022/99" target="_blank">AS <b>2022</b> 99</a>).</p></div>
<div class="collapseable">
<p class=" man-text-align-left "> (Art. 28 para. 3 and 29 para. 1 and 2 let. c No 3)</p>
<section id="annex_6/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_6/lvl_u1">Access categories </a>
</h2>
<div class="collapseable">
<dl>
<dt>1. </dt>
<dd>“3G”: Access for persons with a vaccination, recovery or test certificate or with an exemption certificate under Article 1 letter a number 4 in its version of 3 November 2021<sup><a href="#fn-d6e3539" id="fnbck-d6e3539">87</a></sup>.</dd>
<dt>2. </dt>
<dd>“2G”: Access for persons with a vaccination or recovery certificate or with an exemption certificate under Article 1 letter a number 4 in its version of 3 November 2021<sup><a href="#fn-d6e3557" id="fnbck-d6e3557">88</a></sup>.</dd>
<dt>3. </dt>
<dd>“2G+”: Access for persons with:<dl>
<dt>a. </dt>
<dd>both a vaccination or recovery certificate and a test certificate;</dd>
<dt>b. </dt>
<dd>a vaccination certificate, the period of validity of which did not begin more than 120 days previously;</dd>
<dt>c. </dt>
<dd>a recovery certificate, the period of validity of which did not begin more than 120 days previously and which was not issued on the basis of an antibody test under Article 16 paragraph 3 in its version of 3 November 2021<sup><a href="#fn-d6e3591" id="fnbck-d6e3591">89</a></sup>; or</dd>
<dt>d. </dt>
<dd>an exemption certificate under Article 1 letter a number 4 in its version of 3 November 2021<sup><a href="#fn-d6e3606" id="fnbck-d6e3606">90</a></sup>. </dd>
</dl>
</dd>
<dt>4. </dt>
<dd>“Test certificate”: Access for persons with a test certificate or with an exemption certificate under Article 1 letter a number 4 in its version of 3 November 2021<sup><a href="#fn-d6e3624" id="fnbck-d6e3624">91</a></sup>.</dd>
</dl>
<p></p>
<div class="footnotes">
<p id="fn-d6e3539"><sup><a href="#fnbck-d6e3539">87</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>, <a href="https://fedlex.data.admin.ch/eli/oc/2021/813" target="_blank">813</a></p>
<p id="fn-d6e3557"><sup><a href="#fnbck-d6e3557">88</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>, <a href="https://fedlex.data.admin.ch/eli/oc/2021/813" target="_blank">813</a></p>
<p id="fn-d6e3591"><sup><a href="#fnbck-d6e3591">89</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a></p>
<p id="fn-d6e3606"><sup><a href="#fnbck-d6e3606">90</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>, <a href="https://fedlex.data.admin.ch/eli/oc/2021/813" target="_blank">813</a></p>
<p id="fn-d6e3624"><sup><a href="#fnbck-d6e3624">91</a></sup> <a href="https://fedlex.data.admin.ch/eli/oc/2021/653" target="_blank">AS <b>2021</b> 653</a>, <a href="https://fedlex.data.admin.ch/eli/oc/2021/813" target="_blank">813</a></p>
</div>
</div></section>
</div></section>
</div>
</div></body>
</html>
